Antibody-Cancer Drug Combo Shows Promise Against Aggressive Lymphoma
A cancer-killing compound, called tiancimycin, combined with a cancer-seeking antibody, shows promise against an aggressive type of lymphoma.
A cancer-killing compound, called tiancimycin, combined with a cancer-seeking antibody, shows promise against an aggressive type of lymphoma.